Jubilant Life Sciences

BSE : 530019 | NSE : JUBILANT

Industry : Pharma Drugs | ISIN : INE700A01033 | FreeFloat : 40.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)11,452.13
Net Worth (NW)5,394.75
Intrinsic Worth (IW)16,846.88
Market Cap (MC)8,553.40
Economic Value Added-47.97
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)67.98%
IC Gross Margin (EBITDA/IC)15.90%
IC Net Margin (NPT/IC)7.10%
Knowledge Turnover (Sales/IC)0.87
Market to Intrinsic Value (MC/IW)0.51

As OfIntrinsic ValueMarket Price
31 Dec 2019Rs. 1,057.68Rs. 537.00
22 May 2020 - Rs. 456.20
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 442.38ReduceSell
KB > 50% : Yes50 DMA : Rs. 360.12
0 < M2IV < 1 : YesVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-17
C
1641.42
1651.95
315.51
240.29
160.10
149.03
112.65
Jun-17
C
1596.05
1602.86
344.42
271.94
203.21
143.71
183.18
Sep-17
C
1642.04
1649.13
313.15
234.14
168.13
125.47
205.63
Dec-17
C
2067.76
2070.98
420.06
338.24
261.18
212.84
171.92
Mar-18
C
2251.96
2274.87
480.78
299.04
226.56
152.40
139.08
Jun-18
C
2078.65
2088.12
447.07
359.07
286.37
200.37
214.02
Sep-18
C
2269.49
2273.32
454.01
364.53
301.81
209.77
350.71
Dec-18
C
2377.10
2406.12
522.28
423.88
355.61
267.52
87.28
Mar-19
C
2385.58
2379.00
116.63
21.61
-39.98
-100.65
-88.78
Jun-19
C
2181.86
2191.56
444.30
341.61
269.03
184.98
232.03
Sep-19
C
2265.93
2278.19
480.71
363.87
292.23
249.39
273.20
Dec-19
C
2315.21
2321.24
478.81
365.35
293.32
203.38
252.99
* C - Consolidated, S - Standalone